GGrantIndex
Sort

40,608 grants matching prostate cancer

Translational Research in Cancer

$2,807,751
Karen E Knudsen · Thomas Jefferson University · P30 · FY2017 · CA

Cancer Risk in Human Populations

$2,806,276
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Chemical Receptor Interactions In Reproduction And Hormonal Toxicity

$2,805,027
Kenneth S Korach · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

THE IMPACT OF A GENE EXPRESSION PROFILE ON TREATMENT CHOICE AND OUTCOME AMONG MINORITY MEN NEWLY DIAGNOSED WITH PROSTATE CANCER: A RANDOMIZED TRIAL

$2,804,806
Northwestern University · · FY2015 · Department of the Army

THE IMPACT OF A GENE EXPRESSION PROFILE ON TREATMENT CHOICE AND OUTCOME AMONG MINORITY MEN NEWLY DIAGNOSED WITH PROSTATE CANCER: A RANDOMIZED TRIAL

$2,804,806
University Of Illinois · · FY2015 · Department of the Army

GLOBAL GENOMIC ANALYSIS OF PROSTATE, BREAST AND PANCREATIC CANCER

$2,802,000
Hudsonalpha Institute For Biotechnology · · FY2010 · Department of the Army

Hormone-Related Cancers

$2,799,580
Gretchen Gierach · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

$2,796,917
Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

DISSEMINATING THE INTERACTIVE SUPPORT, COMMUNICATION, AND INFORMATION (SCIPI) TO MEN WITH LOCALIZED PROSTATE CANCER: A MULTISITE PILOT RANDOMIZED CLINICAL TRIAL

$2,788,886
The University Of Texas Health Science Center At San Antonio · · FY2025 · Defense Health Agency

SWOG Biospecimen Bank

$2,777,143
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2017 · CA

National Center for Integrative Biomedical Informatics(RMI)

$2,776,008
Brian David Athey · University Of Michigan At Ann Arbor · U54 · FY2010 · DA

BIOMARKERS FOR EARLY DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER: A MULTI-INSTITUTIONAL VALIDATION TRIAL

$2,773,315
Fred Hutchinson Cancer Research Center · · FY2014 · Department of the Army

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,760,232
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA

PLCO Trial Etiologic and Early Marker Study

$2,752,961
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Hormone-Related Cancers

$2,752,919
Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Early Life Exposures and Subsequent Cancer Risk

$2,752,232
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Cancer Center Support Grant

$2,750,000
Wayne State University · P30 · FY2005 · CA

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,747,943
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2018 · CA

Biology of the Prostate Cancer Prevention Trial (PCPT)

$2,747,394
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA

Cancer Center Support Grant

$2,746,972
John C Ruckdeschel · Wayne State University · P30 · FY2006 · CA

NEW AWARD - IMPACT OF GERMLINE GENETIC TESTING FOR MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE, EFFECTIVE 4/1/2020, SIGNED 3/13/2020, DISTRIBUTED 3/17/2020, FAADC 3/17/2020

$2,744,029
Sloan-Kettering Institute For Cancer Research · · FY2020 · Defense Health Agency

PLCO EEMS and Extended Follow Up

$2,743,757
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

DCTD Cancer Imaging

$2,743,263
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

SWOG Biospecimen Bank

$2,742,584
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2016 · CA

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$2,741,261
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA